WEST LAFAYETTE — Researchers have determined the structure of the rubella virus capsid protein, which is central to the virus’s ability to assemble into an infectious particle and to infect humans.
Although a successful vaccine is available to protect against rubella virus infection, the discovery could aid efforts to develop vaccines and antiviral drugs to treat related infections.
The protein is located on the virus’s inner portion of its shell, or capsid, and is an essential structural component as well as a key factor in virus-host interactions. The new findings reveal a protein structure not previously seen in other viruses that is an essential component of infectious rubella virus, said Michael Rossmann, Purdue University’s Hanley Distinguished Professor of Biological Sciences.
He led a team of researchers at Purdue that discovered the structure, working with researchers at the University of Alberta who created mutated forms of the virus to validate the structural interpretation.
“What we predicted based on the structure is that if we mutated the virus to change the amino acids in a specific region it would destroy the virus and it wouldn’t assemble,” said Purdue doctoral student Vidya Mangala-Prasad, who graduates this semester.
The findings were published in November in Proceedings of the National Academy of Sciences. The paper was authored by Mangala-Prasad; University of Alberta graduate student Steven D. Willows; Purdue research scientist Andrei Fokine; Purdue postdoctoral researchers Anthony J. Battisti, Siyang Sun and Pavel Plevka; Tom Hobman, a professor in the Department of Cell Biology at the University of Alberta; and Rossmann.
“These studies may facilitate future vaccine design as well as aid in development of drugs for other RNA viruses for which there are no therapeutic treatments,” Hobman said.
RNA viruses include those that cause SARS, influenza or hepatitis C.